<span class="articleLocation”>Jan 27 (Reuters) – C.R. Bard Inc said it
reached a preliminary deal with the U.S. Attorney’s Office for
the Northern District of Georgia to resolve claims related to
the medical device maker’s brachytherapy business.

The company would record a charge of about $40.8 million
after tax in the fourth quarter of 2011, it said in a filing
with the U.S. Securities and Exchange Commission.

In November 2006, the company received a subpoena issued by
the U.S. Department of Health and Human Services seeking
documents related to its brachytherapy business.

Brachytherapy is a rapid radiation treatment administered to
cancer patients.

Shares of the company were trading flat at $93.40 on Friday
morning on the New York Stock Exchange.

This entry was posted on Saturday, January 28th, 2012 at 9:02 am and is filed under Business. You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed.